Defence Finance Monitor

Defence Finance Monitor

DNA Script: Enzymatic DNA Synthesis and European Biological Sovereignty

Strategic mapping of DNA Script’s SYNTAX platform. Enabling rapid on-site DNA synthesis for sovereign biothreat detection, medical readiness, and DNA data storage.

Dec 28, 2025
∙ Paid

DNA Script SAS is a Paris-based deep-tech biotechnology company specializing in enzymatic DNA synthesis[1]. Founded in 2014, it has developed the SYNTAX® platform, the world’s first benchtop DNA “printer,” enabling rapid on-site production of custom oligonucleotides for research and diagnostics. Headquartered in Le Kremlin-Bicêtre (Paris metropolitan ar…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Defence Finance Monitor · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture